Owner ZyStor Therapeutics, Inc.

Inventors Beverley, Stephen M.; Lebowitz, Jonathan H.

Agent Pizzeys

Pub. Number AU-B-2002256423

PCT Pub. Number WO2002/087510

Priority 60/329,461 15.10.01 US; 60/287,531 30.04.01 US; 60/304,609 10.07.01 US; 60/351,276 23.01.02 US

Filing date 30 April 2002

Wipo publication date 11 November 2002

Acceptance publication date 24 July 2008

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/203 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/42 (2006.01) Enzymes, e.g. ligases (6.) - acting on beta-1, 4-glucosidic bonds, e.g. cellulase

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids